tetradecanoylphorbol acetate and ym 529

tetradecanoylphorbol acetate has been researched along with ym 529 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanai, Y; Harada, A; Kozawa, O; Ohta, T; Takai, S; Tokuda, H	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and ym 529

Article	Year
Minodronate suppresses prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2006, Volume: 38, Issue:3 Topics: Animals; Cell Line; Dinoprost; Diphosphonates; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-raf; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A	2006

Article

Year

Minodronate suppresses prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2006, Volume: 38, Issue:3

Topics: Animals; Cell Line; Dinoprost; Diphosphonates; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-raf; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A

2006